Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate for consciousness recovery in poisoned patients with reduced consciousness
IRCT20220305054196N4Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in Intoxication comparing Methylphenidate + standard treatment with Placebo/standard treatment control (2 arms). Primary endpoints: Level of consciousness, Duration of intubation and 1 more. Started Mar 2024; status: completed.
02
Drugs
methylphenidate
03
Conditions
Intoxication
Beyond the preview
Go deeper on IRCT20220305054196N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220305054196N4.